Literature DB >> 3134982

Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle.

C Markopoulos1, U Berger, P Wilson, J C Gazet, R C Coombes.   

Abstract

To examine the presence and distribution of oestrogen receptors in the normal breast during the menstrual cycle cytological samples obtained by fine needle aspiration from 69 premenopausal women with normal breasts were analysed immunocytochemically with a monoclonal antibody to oestrogen receptor; samples from 15 postmenopausal women were also analysed. The receptor content of breast cancers from 83 premenopausal women was also determined in relation to when during the menstrual cycle excision was performed. In the normal premenopausal women oestrogen receptors were detected in the nuclei of epithelial cells in 21 out 68 (31%) assessable samples. All 21 of these samples were obtained from the 35 women who were studied during the first half of their menstrual cycle (days 28 to 14). None of the 33 samples obtained during the second half of the cycle contained oestrogen receptors. Samples were assessable in eight of the postmenopausal women, six giving a positive result for oestrogen receptor. Fifty one of the 83 carcinomas were positive for oestrogen receptor, 24 having been excised during the first half of the cycle and 27 during the second half. Production of oestrogen receptor protein is suppressed at the time of ovulation in the normal breast epithelium of premenopausal women. In contrast, breast carcinoma cells either synthesise this protein continuously throughout the cycle or fail to express it despite fluctuations of serum hormone concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134982      PMCID: PMC2545825          DOI: 10.1136/bmj.296.6633.1349

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer.

Authors:  R A McClelland; U Berger; P Wilson; T J Powles; P A Trott; D Easton; J C Gazet; R C Coombes
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

2.  Malignant and benign human mammary disease: estrogen binding in relation to clinical data.

Authors:  L Terenius; H Johansson; A Rimsten; L Thorén
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

3.  Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells.

Authors:  W J King; G L Greene
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

Review 4.  Receptors reconsidered: a 20-year perspective.

Authors:  E V Jensen; G L Greene; L E Closs; E R DeSombre; M Nadji
Journal:  Recent Prog Horm Res       Date:  1982

Review 5.  The morphology of hormone induced structural changes in the female breast.

Authors:  R Bässler
Journal:  Curr Top Pathol       Date:  1970

6.  Pathological review of breast lesions analyzed for estrogen receptor protein.

Authors:  P P Rosen; C J Menendez-Botet; J S Nisselbaum; J A Urban; V Miké; A Fracchia; M K Schwartz
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

7.  The correlation of histologic changes in the human breast with the menstrual cycle.

Authors:  P M Vogel; N G Georgiade; B F Fetter; F S Vogel; K S McCarty
Journal:  Am J Pathol       Date:  1981-07       Impact factor: 4.307

8.  Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast.

Authors:  D J Ferguson; T J Anderson
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

9.  Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality.

Authors:  T J Anderson; D J Ferguson; G M Raab
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

10.  Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay.

Authors:  P Feherty; G Farrer-Brown; A E Kellie
Journal:  Br J Cancer       Date:  1971-12       Impact factor: 7.640

View more
  25 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

Review 2.  Establishing a framework for the functional mammary gland: from endocrinology to morphology.

Authors:  Russell C Hovey; Josephine F Trott; Barbara K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

3.  Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

4.  Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer.

Authors:  S Singh; R Poulsom; N A Wright; M C Sheppard; M J Langman
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 5.  Oestrogen and colonic epithelial cell growth.

Authors:  S Singh; M J Langman
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

6.  A kinetic model identifies phosphorylated estrogen receptor-α (ERα) as a critical regulator of ERα dynamics in breast cancer.

Authors:  Dan Tian; Natalia M Solodin; Prashant Rajbhandari; Kelsi Bjorklund; Elaine T Alarid; Pamela K Kreeger
Journal:  FASEB J       Date:  2015-02-03       Impact factor: 5.191

Review 7.  Estrogen receptor alpha in human breast cancer: occurrence and significance.

Authors:  S Ali; R C Coombes
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

8.  Expression of the estrogen receptor gene in developing and adult human breast.

Authors:  M Boyd; R H Hildebrandt; S A Bartow
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter.

Authors:  Stephanie J Ellison-Zelski; Natalia M Solodin; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2009-07-20       Impact factor: 4.272

Review 10.  Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk.

Authors:  I A Mustafa; K I Bland
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.